Impact of morphine dose on ticagrelor uptake and platelet inhibition in patients with ST-segment elevation myocardial infarction – A substudy from the prospective randomized MOVEMENT trial-Reference-Cited by-同舟云学术

Impact of morphine dose on ticagrelor uptake and platelet inhibition in patients with ST-segment elevation myocardial infarction – A substudy from the prospective randomized MOVEMENT trial

Published:2021-12 Issue: Volume:5 Page:100071
ISSN:2666-5727
Container-title:Thrombosis Update
language:en
Short-container-title:Thrombosis Update

Author:

Holm Manne,Tornvall Per^ORCID,Beck Olof^ORCID,Fux Thomas,van der Linden Jan^ORCID

Publisher

Elsevier BV

Reference14 articles.

1. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding;Tantry;J. Am. Coll. Cardiol.,2013

2. Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study;Parodi;J. Am. Coll. Cardiol.,2013

3. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study;Silvain;Thromb. Haemostasis,2016

4. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial;Kubica;Eur. Heart J.,2016

5. The MOVEMENT trial;Holm;J Am Heart Assoc,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial;Frontiers in Cardiovascular Medicine;2024-04-02

2. Negative Impact of ST-Segment Elevation Myocardial Infarction and Morphine Dose on Ticagrelor Uptake and Pharmacodynamics: A Population PK/PD Analysis of Pooled Individual Participant Data;Clinical Pharmacokinetics;2023-04-25